Medical Advocates
HCV Infection/Disease
  Special Populations

 General Reports                      Mentally Ill
Pregnant Women/Neonates    Veterans
 Children                                  Older Persons
 Healthcare Workers                Homeless
African-Americans                  Misc Populations
Latinos/Latinas 
Dialysis Patients
Hemophiliacs
Substance Users; General
IDUs
MSM
Incarcerated
HCV Main Page Main New/Newsworthy    Home Page    
Last Update:  November 25, 2011
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
General Reports
 

          Journal Papers, Abstracts, and Commentaries

 
Hepatitis C treatment among racial and ethnic groups in the IDEAL trial.
Muir AJ, Hu KQ, Gordon SC,  et al
J Viral Hepat. 2010 Nov 25
 Abstract

Hepatitis C Virus Prevalence and Clearance among US Blood Donors, 2006-2007:
Associations with Birth Cohort, Multiple Pregnancies, and Body Mass Index.
 Murphy EL, Fang J, Tu Y,  et al
 J Infect Dis. 2010 Jul 9
 Abstract

Context of clinical care: the case of hepatitis C in underserved communities--a report
from the Primary Care Multiethnic Network (PRIME Net) Consortium.
 Leverence RR, Williams RL, Pace W, et al
 J Am Board Fam Med. 2009 Nov-Dec;22(6):638-46.
 Abstract

Evaluation of immigration status, race and language barriers on chronic hepatitis C virus
infection management and treatment outcomes.
 Giordano C, Druyts EF, Garber G, Cooper C. 
Eur J Gastroenterol Hepatol. 2009 Mar 21.
 Abstract
 
Anti-HCV positivity in sexual partners and offspring of patient with chronic hepatitis C.
 Aykın N, Cevık F, Demırturk N, 
Scand J Infect Dis. 2008;40(6):533-537.
Abstract
 
A WEEK-IN-REVIEW FEATURED REPORT
FULL-TEXT ARTICLE
 Treatment of chronic HCV infection in special populations.
 Hoefs J, Aulakh VS.
nt J Med Sci. 2006;3(2):69-74.
 Paper
 
HIV, hepatitis C and HIV/hepatitis C virus co-infection in vulnerable populations.
 Backus LI, Boothroyd D, Deyton LR.  
AIDS. 2005 Oct;19 Suppl 3:S13-9.
 Abstract

Treatment of hepatitis C in special populations.
 Moylan CA, Muir AJ. 
Clin Liver Dis. 2005 Nov;9(4):567-77.
 Abstract
African-Americans
 

General Reports

          Journal Papers, Abstracts, and Commentaries

 
Complete blood count, measures of iron status and inflammatory markers in
inner-city African Americans with undiagnosed Hepatitis C seropositivity.
Ufearo H, Kambal K, Onojobi GO,  et al
Clin Chim Acta. 2010 Jan 28
 Abstract

Treatment options for hepatitis C and the rationale for low response rates in
African Americans.
 Manka C, Gomes R, Reviere R, Lee C
.J Natl Med Assoc. 2009 Jun;101(6):604-8.
 Abstract

Hepatitis C Hypervariable Region 1: Association of Reduced Selection Pressure in African
Americans with Treatment Failure.
 Park VM, Mason BC, Krushkal J, et al
Dig Dis Sci. 2007 Apr 5;
Abstract
 
Hepatitis C in African Americans.
Pyrsopoulos N, Jeffers L
J Clin Gastroenterol. 2007 Feb;41(2):185-193.
Abstract
 
Hepatitis C virus infection in African Americans.
 Pearlman BL.
Clin Infect Dis. 2006 Jan 1;42(1):82-91.
 Abstract
 
Management of hepatitis C virus in special populations: Patient and treatment considerations.
Gish RG, Afdhal NH, Dieterich DT, Reddy KR.
Clin Gastroenterol Hepatol. 2005 Apr;3(4):311-8
 Abstract

Chronic hepatitis C in African Americans and other minority groups.
Fleckenstein J. 
Curr Gastroenterol Rep. 2004 Feb;6(1):66-70.
 Abstract

Peginterferon alfa-2b and ribavirin for the treatment of chronic hepatitis C in blacks and
non-Hispanic whites.
Muir AJ, Bornstein JD, Killenberg PG, et al
N Engl J Med. 2004 May 27;350(22):2265-71.
 Abstract
 
Racial differences in hepatitis B and hepatitis C and associated risk behaviors in veterans
with severe mental illness.
Butterfield MI, Bosworth HB, Stechuchak KM, et al 
J Natl Med Assoc. 2004 Jan;96(1):43-52
 Abstract
 
Comparison of 125I-interferon-alpha binding to peripheral blood cells from African-Americans
and Caucasians with hepatitis C.
Kimball P, Verbeke S, Shiffman M.
J Viral Hepat. 2003 Sep;10(5):354-9.
 Abstract
 
Relationship between transferrin saturation and iron stores in the African American and
US Caucasian populations: analysis of data from the third National Health and Nutrition
Examination Survey.
McLaren CE, Li KT, Gordeuk VR, et al
Blood. 2001 Oct 15;98(8):2345-5
 Abstract

Epidemiology/Incidence/Natural History

          Journal Papers, Abstracts, and Commentaries

 
Hepatitis C and its risk management among drug injectors in London: renewing harm
reduction in the context of uncertainty.
 Rhodes T, Davis M, Judd A.
Addiction. 2004 May;99(5):621-33.
 Abstract

Hepatitis C infection in African Americans: its natural history and histological progression.
Wiley TE, Brown J, Chan J.
Am J Gastroenterol. 2002 Mar;97(3):700-6
 Abstract

Treatment

     General Reports

           Journal Papers, Abstracts, and Commentaries

  Treatment of Chronic Hepatitis C Virus in African Americans With Genotypes 2 and 3.
 Shiffman ML, Mihas AA, Millwala F, et al 
Am J Gastroenterol. 2007 Feb 22
 Abstract

      Interferon- alpha 2b

            Journal Papers, Abstracts, and Commentaries

 
Hepatitis C and its risk management among drug injectors in London: renewing harm reduction
in the context of uncertainty.
 Rhodes T, Davis M, Judd A.
Addiction. 2004 May;99(5):621-33.
 Abstract

Intensive interferon therapy does not increase virological response rates in African Americans with
chronic hepatitis C.
Theodore D, Shiffman ML, Sterling RK, et al
Dig Dis Sci. 2003 Jan;48(1):140-5.
Abstract
 
African Americans with genotype 1 treated with interferon for chronic hepatitis C have
a lower end of treatment response than Caucasians.
Kinzie JL, Naylor PH, Nathani MG, t al
J Viral Hepat. 2001 Jul;8(4):264-9.
Abstract

      Interferon- alpha 2b/Ribivirin

            Journal Papers, Abstracts, and Commentaries

  Viral dynamics and response differences in HCV-infected African American and white patients
treated with IFN and ribavirin.
Layden-Almer JE, Ribeiro RM, Wiley T,
Hepatology. 2003 Jun;37(6):1343-50.
 Abstract
Latinos/Latinas
         

           Journal Papers, Abstracts, and Commentaries

 
Prevalence of HCV Risk Factors in Hispanic-American Sub Populations.
 Trooskin SB, Vega M, Herrine SK, et al
J Immigr Minor Health. 2009 Sep 1.
 Abstract

Chronic hepatitis C in latinos: natural history, treatment eligibility, acceptance, and outcomes.
 Cheung RC, Currie S, Shen H, al 
Am J Gastroenterol. 2005 Oct;100(10):2186-93.
 Abstract
Older Persons
 

          Journal Papers, Abstracts, and Commentaries

 
Hepatitis C in the Elderly: Epidemiology, Natural History, and Treatment.
 Mindikoglu AL, Miller RR.
Clin Gastroenterol Hepatol. 2008 Dec 10
 Abstract
 
Treatment Eligibility and Outcomes in Elderly Patients with Chronic Hepatitis C: Results
from the VA HCV-001 Study.
 Tsui JI, Currie S, Shen H, et al 
Dig Dis Sci. 2007 Sep 1;
 Abstract

Hepatitis C in 6,865 Patients 65 yr or Older: A Severe and Neglected Curable Disease?
Thabut D, Le Calvez S, Thibault V, et al
Am J Gastroenterol. 2006 Jun;101(6):1260-7.
 Abstract
Healthcare Workers
         

          Journal Papers, Abstracts, and Commentaries

  Favorable outcome of acute occupational hepatitis C in healthcare workers:
a multicenter French study on 23 cases.
Morin T, Pariente A, Lahmek P.
 Eur J Gastroenterol Hepatol. 2011 Jun;23(6):515-20.
 Abstract

Pilot study of postexposure prophylaxis for hepatitis C virus in healthcare workers.
 Corey KE, Servoss JC, Casson DR, et al
 Infect Control Hosp Epidemiol. 2009 Oct;30(10):1000-5.
 Abstract
Hemophiliacs
 

          Journal Papers, Abstracts, and Commentaries

 
Beneficial effect of successful HCV treatment in patients with inherited bleeding disorders,
assessed by liver stiffness measurements.
 Fransen van de Putte DE, Fischer K,  et al
 Haemophilia. 2011 Nov 21..
 Abstract

Liver stiffness measurements to assess progression of fibrosis in HCV-infected patients with
inherited bleding disorders.
Fransen van de Putte DE, Fischer K, et al
Haemophilia. 2011 Apr 27.
 Abstract

Patient-Care Practices Associated with an Increased Prevalence of Hepatitis C Virus
Infection among Chronic Hemodialysis Patients.
Shimokura G, Chai F, Weber DJ, et al
Infect Control Hosp Epidemiol. 2011 May;32(5):415-24..
 Abstract

Previously unrecognized advanced liver disease unveiled by transient elastography in patients
with Haemophilia and chronic hepatitis C.
 Moessner BK, Andersen ES, Weis N, et al
Haemophilia. 2011 Mar 24
 Abstract

Meta-analysis of factors associated with sustained viral response in patients on
hemodialysis treated with standard or pegylated interferon for hepatitis C infection.
 Alavian SM, Tabatabaei SV. 
Iran J Kidney Dis. 2010 Jul;4(3):181-94.
 Abstract

Correlates of high hepatitis C virus RNA load in a cohort of HIV-negative
and HIV-positive individuals with haemophilia.
 Gadalla SM, Preiss LR, Eyster ME, Goedert JJ.
J Viral Hepat. 2010 Mar 8
 Abstract

Efficacy and safety of pegylated interferon alpha-2a therapy for chronic hepatitis C
in HIV-infected patients with haemophilia.
 Zhang RF, Sun HQ, Huang Q,  et al 
Haemophilia. 2009 Dec 20
 Abstract

Evidence of recombination in Hepatitis C Virus populations infecting a hemophiliac patient.
 Moreno P, Alvarez M, Lopez L, et al
Virol J. 2009 Nov 18;6(1):203.
Abstract

Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in
persons with haemophilia.
 Angelotta C, McKoy JM, Fisher MJ, et al 
Vox Sang. 2007 Aug;93(2):159-65.
 Abstract
 
FULL-TEXT ARTICLE
 High efficacy of combined therapy with pegylated interferon plus ribavirin in patients
with hemophilia and chronic hepatitis C.
 Mancuso ME, Rumi MG, Santagostino E, et al 
Haematologica. 2006 Oct;91(10):1367-71.
 Paper
 
Treatment of chronic hepatitis C in patients with haemophilia: a review of the literature.
Posthouwer D, Mauser-Bunschoten EP. et al
Haemophilia. 2006 Sep;12(5):473-8.
Abstract
 
Treatment of hepatitis C in hemophiliacs.
Franchini M, Nicolini N, Capra F.
 Am J Hematol. 2006 Sep;81(9):696-702.
Abstract

Hepatitis C at the Israeli national hemophilia center.
Maor Y, Bashari D, Kenet G, et al
 Haemophilia. 2006 Jan;12(1):68-74.
Abstract
 
Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in
hemodialysis patients.
 Bouzgarrou N, Fodha I, Othman SB, et al 
J Med Virol. 2005 Oct 27;77(4):502-508
Abstract
 
Hepatitis C and health-related quality of life among patients with hemophilia.
 Posthouwer D, Plug I, van der Bom JG, et al 
Haematologica. 2005 Jun;90(6):846-50
 Abstract
 
Prolonged time until seroconversion among hemodialysis patients: the need for HCV PCR.
 Schroeter M, Zoellner B, Polywka S, Laufs R, Feucht HH. 
Intervirology. 2005 Jul-Aug;48(4):213-5
 Abstract

Hepatitis C in haemophilia: lights and shadows.
 Rumi MG, De Filippi F, Santagostino E, Colombo M. 
Haemophilia. 2004 Oct;10 Suppl 4:211-5
 Abstract
 
  Sustained suppression of hepatitis C virus by high doses of interferon and ribavirin in adult
hemophilic patients.
 Santagostino E, De Filippi F, Rumi MG,  
 Transfusion. 2004 May;44(5):790-4
 Abstract
 
  Transjugular liver biopsy is safe and diagnostic for patients with congenital bleeding disorders
and hepatitis C infection.
 DiMichele DM, Mirani G, Wilfredo Canchis P, et al
Haemophilia. 2003 Sep;9(5):613-618.
 Abstract
 
  Interferon and ribavirin in HIV-negative haemophiliacs with chronic hepatitis C who were
nonresponders to a previous interferon treatment.
 Franchini M, Rossetti G, Capra F, et al.
Haemophilia 2002 Nov;8(6):794-797
 Abstract
 
  Update on chronic hepatitis C in hemophiliacs.
 Franchini M, Capra F, Tagliaferri A
 Haematologica 2002 May;87(5):542-9
 Abstract
 
  The natural history and antiviral treatment of hepatitis C in haemophilia.
 Lee C, Dusheiko G.
Haemophilia 2002 May;8(3):322-9
 Abstract
Dialysis Patients
 

     Journal Papers, Abstracts, and Commentaries
 
Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy.
Deltenre P, Moreno C, Tran A,  et al
Aliment Pharmacol Ther. 2011 Jun 20.
Abstract

Decreased prevalence and incidence of HCV markers in haemodialysis units: a multicentric
French survey.
Sauné K, Kamar N, Miédougé M,  et al
Nephrol Dial Transplant. 2010 Nov 19.
Abstract

Hemodialysis of Patients with HCV Infection: Isolation Has a Definite Role.
Agarwal SK.
Nephron Clin Pract. 2010 Nov 3;117(4):c328-c332
 Abstract

The quality of life in hemodialysis patients with chronic hepatitis C virus infection.
 Akyüz F, Beşişik F, Pinarbaşi B, et al 
Turk J Gastroenterol. 2009 Dec;20(4):243-6
 Abstract

Treatment of a common problem in Hemodialysis patients: Is the juice worth the squeeze?
 Al-Saran K, Sabry A, Shaheen N, Yehia A.
 Saudi J Kidney Dis Transpl. 2009 Sep-Oct;20(5):876-82.
 Abstract

Hepatitis C Infection and the Risk of Bacteremia in Hemodialysis Patients with Tunneled Vascular
Access Catheters.
Reddy S, Sullivan R, Zaiden R,
South Med J. 2009 Mar 9
 Abstract
 
FULL-TEXT ARTICLE
Hepatitis C virus transmission at an outpatient hemodialysis unit--New York, 2001-2008.
 Centers for Disease Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep. 2009 Mar 6;58(8):189-94
 Paper
 
FULL-TEXT ARTICLE
 A shield against a monster: Hepatitis C in hemodialysis patients.
Alavian SM.
 World J Gastroenterol. 2009 Feb 14
 Paper
 
Quality of life is not related with liver disease severity but with anemia, malnutrition, and depression
in HCV-infected hemodialysis patients.
Afsar B, Ozdemir NF, Sezer S, Haberal M.
 Hemodial Int. 2009 Jan;13(1):62-71
 Abstract
 
Reduction of hepatitis C virus using lectin affinity plasmapheresis in dialysis patients.
Tullis RH, Duffin RP, Handley HH, et al
 Blood Purif. 2009;27(1):64-9.
Abstract
 
Hepatitis C Virus Infection in Haemodialysis: The 'No-Isolation' Policy Should Not Be Generalized.
 Agarwal SK, Dash SC, Gupta S, Pandey RM. 
Nephron Clin Pract. 2009 Jan 16;111(2):c133-c140.
 Abstract
 
Treatment of chronic hepatitis C in hemodialysis patients.
 Berenguer M.  
Hepatology. 2008 Nov;48(5):1690-9.
 Abstract
 
Hepatitis C Is Less Aggressive in Hemodialysis Patients than in Nonuremic Patients.
 Trevizoli JE, de Paula Menezes R, Ribeiro Velasco LF
Clin J Am Soc Nephrol. 2008 Jul 23.
 Abstract
 
Hepatitis C in Dialysed Patients - What Is the Current Optimal Treatment?
 Kes P, Basic-Jukic N.   
 Kidney Blood Press Res. 2007 Apr 20;30(3):156-161
 Abstract
 
FULL TEXT ARTICLE
Acute hepatitis C virus infection assessment among chronic hemodialysis patients in the
Southwest Parana State, Brazil.
 Engel M, Malta FM, Gomes MM 
BMC Public Health. 2007 Apr 4;7:50.
Paper
 
Effects of Adding Ribavirin to Interferon to Treat Chronic Hepatitis C Infection: A Systematic
Review and Meta-analysis of Randomized Trials.
 Brok J, Gluud LL, Gluud C. 
Arch Intern Med. 2005 Oct 24;165(19):2206-12.
Abstract
 
Efficacy of Interferon-alpha in the Treatment of Chronic Hepatitis C in Dialysis Patients: Two Therapeutic
Protocols Compared.
 Grgurevic I, Vince A, Buljevac M, et al 
Nephron Clin Pract. 2005 Dec 21;103(1):c8-c11
Abstract
 
Risk factors for hepatitis C virus infection in patients on long-term hemodialysis.
 Khokhar N, Alam AY, Naz F, Mahmud SN.
 J Coll Physicians Surg Pak. 2005 Jun;15(6):326-8.
 Abstract
 
Transmission of hepatitis C virus between hemodialysis patients sharing the same machine.
 Sartor C, Brunet P, Simon S, et al 
Infect Control Hosp Epidemiol. 2004 Jul;25(7):609-11.
 Abstract
 
FULL-TEXT ARTICLE
 Natural history of chronic hepatitis C in patients on hemodialysis: Case control study with
4-23 years of follow-up.
 Okuda K, Yokosuka O.
World J Gastroenterol. 2004 Aug 1;10(15):2209-12
 Paper
 
Treatment of Early Diagnosed HCV Infection in Hemodialyzed Patients with Interferon-alpha.
Treatment of Hepatitis C.
 Urbanek P, Tesar V, Prochazkova-Francisci E, et al
Blood Purif. 2004 Jul 16;22(4):344-350.
 Abstract

Outbreak of hepatitis C virus infection in a hemodialysis unit: potential transmission by the
hemodialysis machine?
Delarocque-Astagneau E, Baffoy N
 Infect Control Hosp Epidemiol 2002 Jun;23(6):328-34
 Abstract

High prevalence of hepatitis C infection among patients receiving hemodialysis at an
urban dialysis center.
Sivapalasingam S, Malak SF, Sullivan JF, et al.
Infect Control Hosp Epidemiol 2002 Jun;23(6):319-24
 Abstract

Dialysis-Membrane-Dependent Reduction and Adsorption of Circulating Hepatitis C Virus
during Hemodialysis.
Mizuno M, Higuchi T, Yanai M, et al
Nephron 2002 Jun;91(2):235-42
 Abstract

L-carnitine administration reverses acute mental status changes in a chronic hemodialysis 
patient with hepatitis C infection.
DaVanzo WJ, Ullian ME.
Clin Nephrol 2002 May;57(5):402-5
 Abstract

Significance of parenteral iron administration for HCV-positive hemodialysis patients
 Kurihara I, Saito T.
 Nippon Jinzo Gakkai Shi 2002 May;44(4):389-95
 Abstract

Leukopenia and thrombocytopenia in hemodialysis patients with hepatitis B or C virus
infection and non-hemodialysis patients with hepatitis cirrhosis.
 Ng YY, Lin CC, Wu SC, Hwang SJ, et al.
 Clin Nephrol 2002 Apr;57(4):289-95
Abstract

 
Substance Users: General Reports
IDUs
          Journal Papers, Abstracts, and Commentaries
 
 
Management of hepatitis C virus (HCV) infection in drug substitution programs.
Witteck A, Schmid P, Hensel-Koch K,  et al
Swiss Med Wkly. 2011 May 27;141:w13193.
 Abstract

Clinical Experience with the Treatment of Hepatitis C Infection in Patients on Opioid
Pharmacotherapy.
 Sasadeusz JJ, Dore G, Kronborg I,  et al
Addiction. 2010 Dec 16.
Abstract

Effects of Buprenorphine and Hepatitis C on Liver Enzymes in Adolescents and Young Adults.
 Bogenschutz MP, Abbott PJ, Kushner R, et al
J Addict Med. 2010 Dec;4(4):211-216.
 Abstract

Evidence for the effectiveness of sterile injecting equipment provision in preventing
hepatitis C and human immunodeficiency virus transmission among injecting drug users:
a review of reviews.
Palmateer N, Kimber J, Hickman M, et al.
Addiction. 2010 May;105(5):844-59.
Abstract

Effectiveness of chronic hepatitis C treatment in drug users in routine clinical practice:
results of a prospective cohort study [France]
 Melin P, Chousterman M, Fontanges T, et al
Eur J Gastroenterol Hepatol. 2010 Mar 25
 Abstract

Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions
of clients and health professionals.
Treloar C, Newland J, Rance J, Hopwood M.
J Viral Hepat. 2010 Jan 13.
Abstract

Determinants of successful chronic hepatitis C case finding among patients receiving
opioid maintenance treatment in a primary care setting.
 Senn O, Seidenberg A, Rosemann T.
Addiction. 2009 Dec;104(12):2033-2038
 Abstract

Short-term treatment of Hepatitis C in heroin-dependent patients.
 Kristensen O, Sundøy A, Skeie K,  et al
Tidsskr Nor Laegeforen. 2009 Aug 27;129(16):1639-1642
 Abstract

Hepatitis C treatment in patients with drug addiction: clinical management
of interferon-alpha-associated psychiatric side effects.
 Schaefer M, Mauss S.
Curr Drug Abuse Rev. 2008 Jun;1(2):177-87.
 Abstract

Gender Differences in HIV and Hepatitis C Related Vulnerabilities Among Aboriginal Young People
Who Use Street Drugs in Two Canadian Cities.
Partnership FT, Mehrabadi A, Paterson K, et al
 Women Health. 2008;48(3):235-60.
 Abstract
 
Homelessness, drug use and Hepatitis C: A complex problem explored within the context of
social exclusion.
 Neale J.
Int J Drug Policy. 2007 Oct 23;
 Abstract
 
Management of hepatitis C among drug user patients.
 Moussalli J, Melin P, Wartelle-Bladou C, Lang JP.
Gastroenterol Clin Biol. 2007 Aug-Sep;31(8-9 Pt 3):51-5.
 Abstract
 
Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users.
 Grebely J, Raffa JD, Lai C, et al
Can J Gastroenterol. 2007 Jul;21(7):447-51.
 Abstract
 
Treatment for hepatitis C virus and cannabis use in illicit drug user patients: implications and
questions
 Fischer B, Reimer J, Firestone M, et al 
Eur J Gastroenterol Hepatol. 2006 Oct;18(10):1039-42.
 Abstract
 
Cannabis use improves retention and virological outcomes in patients treated for hepatitis C.
 Sylvestre DL, Clements BJ, Malibu Y.
Eur J Gastroenterol Hepatol. 2006 Oct;18(10):1057-63
 Abstract

Psychiatric and Substance Use Disorders in Individuals with Hepatitis C : Epidemiology and
Management.
 Loftis JM, Matthews AM, Hauser P
 Drugs. 2006;66(2):155-174
 Abstract
Veterans
 
United States  
   
          Journal Papers, Abstracts, and Commentaries
 
 
Implications of rapid virological response in hepatitis C therapy in the US veteran population.
Hwang EW, Thomas IC, Cheung R, Backus LI.
Aliment Pharmacol Ther. 2011 Nov 7.
 Abstract

Gaps in the Achievement of Effectiveness of HCV Treatment in National VA Practice.
Kramer JR, Kanwal F, Richardson P, et al
J Hepatol. 2011 Jul 11
 Abstract

A Comparison of Treatment Eligibility for HCV in HCV Monoinfected vs. HCV/HIV Coinfected Persons in
ERCHIVES (Electronically Retrieved Cohort of HCV Infected Veterans).
 Butt AA, McGinnis K, Skanderson M, Justice A.
AIDS Res Hum Retroviruses. 2011 Feb 22
 Abstract

Dietary History and Physical Activity and Risk of Advanced Liver Disease in Veterans with
Chronic Hepatitis C Infection.
 White DL, Richardson PA, Al-Saadi M, et al
Dig Dis Sci. 2010 Dec 28.
 Abstract

Hepatitis C and the Risk of Kidney Disease and Mortality in Veterans With HIV.
 Fischer MJ, Wyatt CM, Gordon K,, et al
J Acquir Immune Defic Syndr. 2010 Feb;53(2):222-226.
 Abstract

Program Characteristics Associated With Testing for HIV and Hepatitis C in Veterans
Substance Use Disorder Clinics.
McInnes DK, Hyun JK, Trafton JA,et al
 Psychiatr Serv. 2010 Jan;61(1):90-94.
 Abstract

Management of Chronic Hepatitis C in Veterans: The Potential of Integrated Care Models.
 Ho SB, Groessl E, Dollarhide A, et al 
Am J Gastroenterol. 2008 Jun 16
 Abstract
 
Racial Differences in the Evaluation and Treatment of Hepatitis C Among Veterans:
A Retrospective Cohort Study.
 Rousseau CM, Ioannou GN, Todd-Stenberg JA, et al
 Abstract
 
Predictors of response of U.S. veterans to treatment for the hepatitis C virus.
 Backus LI, Boothroyd DB, Phillips BR, Mole LA.
 Hepatology. 2007 Jul;46(1):37-47.
 Abstract
 
Screening for hepatocellular carcinoma among veterans with hepatitis C on disease stage,
treatment received, and survival.
 Leykum LK, El-Serag HB, Cornell J, Papadopoulos KP.
Clin Gastroenterol Hepatol. 2007 Apr;5(4):508-12.
 Abstract
 
Management of Hepatitis C Disease Among VA Patients With Schizophrenia and
Substance Use Disorders.
 Huckans MS, Blackwell AD, Harms TA, Hauser P. 
Psychiatr Serv. 2006 Mar;57(3):403-6.
 Abstract
 
Survival in hepatitis C and HIV co-infection: A cohort study of hospitalized veterans.
 El-Serag HB, Giordano TP, Kramer J, et al   
Clin Gastroenterol Hepatol. 2005 Feb;3(2):175-83
 Abstract
 
The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S.
veterans with hepatitis C.
 Kramer JR, Giordano TP, Souchek J, et al 
Am J Gastroenterol. 2005 Jan;100(1):56-63.
 Abstract
 
Elevated prevalence of hepatitis C infection in users of United States veterans medical centers.
Dominitz JA, Boyko EJ, Koepsell TD, et al
Hepatology. 2004 Dec 23;41(1):88-96 [
 Abstract
 
Influence of alcohol use, race, and viral coinfections on spontaneous HCV clearance in a
US veteran population.
 Piasecki BA, Lewis JD, Reddy KR, et al 
Hepatology. 2004 Sep 20;40(4):892.
 Abstract
 
Combination therapy for the treatment of hepatitis C in the veteran population: higher than
expected rates of therapy discontinuation.
 Getachew Y, Browning JD, Prebis M, et al
 Aliment Pharmacol Ther. 2004 Sep 15;20(6):629-36.
Abstract
 
Racial differences in hepatitis B and hepatitis C and associated risk behaviors in veterans
with severe mental illness.
 Butterfield MI, Bosworth HB, Stechuchak KM, et al 
J Natl Med Assoc. 2004 Jan;96(1):43-52
 Abstract

Prevalence of Hepatitis C virus infection in a sample of homeless veterans.
 Desai RA, Rosenheck RA, Agnello V.
Soc Psychiatry Psychiatr Epidemiol. 2003 Jul;38(7):396-401
Abstract
Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans
with human immunodeficiency virus infection.
 Fultz SL, Justice AC, Butt AA, et al.  
Clin Infect Dis 2003 Apr 15;36(8):1039-46
Abstract
Psychiatric disorders among veterans with hepatitis C infection.
 el-Serag HB, Kunik M, Richardson P, Rabeneck L.
Gastroenterology 2002 Aug;123(2):476-82
Abstract
Spectrum of disease in U.S. veteran patients with hepatitis C.
 Nguyen HA, Miller AI, Dieperink E, et al.
Am J Gastroenterol 2002 Jul;97(7):1813-20
 Abstract
 
Mentally Ill
 

     Journal Papers, Abstracts, and Commentaries

 
Guideline-concordant hepatitis C virus testing and notification among patients with and without
mental disorders.
 Kilbourne AM, McCarthy JF, Himelhoch S, et al
Gen Hosp Psychiatry. 2008 Nov-Dec;30(6):495-500
 Abstract
 
Hepatitis C Services and Individuals with Serious Mental Illness.
 Goldberg RW, Seth P
Community Ment Health J. 2008 May 9
Abstract
 
Comparison of hepatitis C treatment patterns in patients with and without psychiatric
and/or substance use disorders
 Chainuvati S, Khalid SK, Kancir S, et al 
J Viral Hepat. 2006 Apr;13(4):235-41.
 Abstract
 
Psychiatric and Substance Use Disorders in Individuals with Hepatitis C : Epidemiology and
Management.
 Loftis JM, Matthews AM, Hauser P
Drugs. 2006;66(2):155-174
 Abstract
 
Hepatitis C virus and HIV co-infection in people with severe mental illness and substance use
disorders.
 Rosenberg SD, Drake RE, Brunette MF, et al 
AIDS. 2005 Oct;19 Suppl 3:S26-33.
Abstract
 
Racial differences in hepatitis B and hepatitis C and associated risk behaviors in veterans
with severe mental illness.
 Butterfield MI, Bosworth HB, Stechuchak KM, et al 
J Natl Med Assoc. 2004 Jan;96(1):43-52.
Abstract

Adherence and mental side effects during hepatitis C treatment with interferon alfa and
ribavirin in psychiatric risk groups.
 Schaefer M, Schmidt F, Folwaczny C, et al.
Hepatology 2003 Feb;37(2):443-51
 Abstract

Prevalence of hepatitis C among psychiatric patients in the public sector.
 Dinwidie SH, Shicker L, Newman T.
Am J Psychiatry 2003 Jan;160(1):172-4
 Abstract
 
Homeless
         

     Conference Reports, Abstracts, and Posters

  Implementation and evaluation of a homeless hepatitis C clinic: An academic and community partnership
 C Rongey, P Gregerson, G Ryan, et al
(136 APHA)
 Abstract
 
Access to health care for homeless people with hepatitis C in Toronto, Canada
KS. Mason, E Khandor 
(136 APHA)
 Abstract
Miscellaneous Populations
 

     Journal Papers, Abstracts, and Commentaries

 
Semen and hormonal parameters in men with chronic hepatitis C infection.
Hofny ER, Ali ME, Taha EA, et al
Fertil Steril. 2011 May 26.
Abstract

FULL-TEXT ARTICLE
Hepatitis C virus infection among adolescents and young adults --- Massachusetts, 2002--2009.
Centers for Disease Control and Prevention (CDC).
 MMWR Morb Mortal Wkly Rep. 2011 May 6;60(17):537-41.
 Paper

Homelessness, drug use and Hepatitis C: A complex problem explored within the context of
social exclusion.
 Neale J.
Int J Drug Policy. 2007 Oct 23;
Abstract
 
Hepatitis C Infection Is Associated with Lower Lipids and High-Sensitivity C-Reactive Protein in
HIV-Infected Men.
 Floris-Moore M, Howard AA, et al 
AIDS Patient Care STDS. 2007 Jul;21(7):479-91.
 Abstract
 
Limitation of combination therapy of interferon and ribavirin for older patients with chronic
hepatitis C.
Iwasaki Y, Ikeda H, Araki Y, et al 
Hepatology. 2006 Jan;43(1):54-63.
 Abstract
 
Differences in treatment outcome for hepatitis C among ethnic groups.
 Hepburn MJ, Hepburn LM, Cantu NS, et al 
Am J Med. 2004 Aug 1;117(3):163-8
 Abstract
 
Hepatitis C Virus Infection in San Francisco's HIV-infected Urban Poor.
 Hall CS, Charlebois ED, Hahn JA,  et al
J Gen Intern Med. 2004 Apr;19(4):357-65.
 Abstract

Hepatitis C in urban and rural public safety workers
 Rischitelli G, McCauley L, Lambert WE, et al
 J Occup Environ Med 2002 Jun;44(6):568-73
 Abstract

Prevalence of hepatitis C in U.S. Army aircrew: do flaws in the data exist?
 Gorbandt MB.
 Aviat Space Environ Med 2002 May;73(5):488-95
 Abstract

Hepatitis C virus infection in young, low-income women: the role of sexually transmitted infection
as a potential cofactor for HCV infection.
 Page-Shafer KA, Cahoon-Young B, Klausner JD
 Am J Public Health 2002 Apr;92(4):670-6
 Abstract

  

     Conference Reports, Abstracts, and Posters
  CONFERENCE PRESENTATION
 Special Populations
 Strader DB
 [NIH Consensus Development Conference on  Management of Hepatitis C: 2002]
 Report

HCV Main Page Main New/Newsworthy    Home Page    

HCV Special Populations